Publications
5539 Results
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11): #3488
- Year
- 2005
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
SNP genotypes show association with common toxicities during both VAD induction and high dose melphalan with autologous transplant support in Intergroup trial S9321 for myeloma: from the bank on a cure
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11): #1169
- Year
- 2005
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0204
SWOG 0204; phase 2 trial of thalidomide (T) + dexamethasone (D) induction followed by tandem autotransplant (TAT) and prednisone (P) + T maintenance for multiple myeloma (MM)
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11): #3489
- Year
- 2005
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
SNP genotypes as prognostic factors associated with staging in myeloma: the first combined SNP association analysis of SWOG, ECOG, and MRC clinical trials from the Bank on a Cure
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11): #5116
- Year
- 2005
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0120
Differential antigenic targets of anti-tumor immune response and selective immunity to stem cell associated group B SOX proteins in preneoplastic versus malignant gammopathy
- Journal / Conference
- Blood 106(11):#1192
- Year
- 2005
- Research Committee(s)
- Leukemia
- Study Number(s)
- E2997
Cytogenetic studies of 539 chronic lymphocytic leukemia (CLL) patients
- Journal / Conference
- Blood 106(11):#2943
- Year
- 2005
- Research Committee(s)
- Leukemia
- Study Number(s)
- E2997
Expression of T cell co-stimulator (ICOS) and its ligand and disease progression in B-cell chronic lymphocytic leukemia.
- Journal / Conference
- Blood (ASH Annual Meeting Abstracts) 106(11):#894
- Year
- 2005
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)
Phase III trial of all-trans retinoic acid (ATRA) vs daunorubicin (D) and cytosine arabinoside (A) as induction therapy and ATRA vs observation as maintenance therapy for children with newly diagnosed acute promyelocytic leukemia (APL)
- Journal / Conference
- Blood 106(11): #546
- Year
- 2005
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)
Very poor survival of patients with AML who relapse after achieving a first complete remission: the Eastern Cooperative Oncology Group experience.
- Journal / Conference
- Blood 105(1):49-53
- Year
- 2005
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9108 (CALGB-9011)
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparatiave analysis of CALGB 9712 and CALGB 9011
- Journal / Conference
- Genes, chromosomes & Cancer 44:279-291
- Year
- 2005
- Research Committee(s)
- Leukemia
- PMID
- PMID16015647